Monitoring agency report for the quarter ended September 30, 2026 i.r.o. QIP of Rs. 600 crores.

November 3, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Sub: Monitoring Agency Report issued by CRISIL Ratings Limited in respect of utilisation of proceeds raised through Qualified Institutional Placement Issue (“QIP”) for the quarter ended September 30, 2026 under regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 as amended from time to time, (“Listing Regulations”). Dear Sir/Madam, Pursuant to Regulation 32 of Listing Regulations, we enclose herewith Monitoring Agency Report issued by CRISIL Ratings Limited appointed to monitor the utilization of the proceeds raised through QIP for the quarter ended September 30, 2026. The Report has been duly reviewed by the Audit Committee at its meeting held on October 31, 2026. Furthermore, we hereby confirm that there has been no deviation or variation in the utilization of proceeds of funds raised through issue of Equity Shares on QIP basis. This intimation is also being uploaded on the Company’s website at https://neogenchem.com/wp- content/uploads/ma-report-qip-25-26.pdf and at the website of the National Stock Exchange of India Limited (www.nseindia.com) and BSE Limited (www.bseindia.com) . Kindly take the above on your record and disseminate the same for the information of investors. Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary & Compliance Officer Mem. No: A35131 Encl: A/a Registered Office: 1002, Dev Corpora, Cadbury Junction, E: investor@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 Monitoring Agency Report Neogen Chemicals Limited for the quarter ended September 30, 2026 CRL/MAR/ NECL /2026-27/2092 November 03, 2026 Neogen Chemicals Limited 1002, Dev Corpora Building, 10th Floor, Opp. Cadbury Junction, Off Pokhran Road No 2, Khopat Thane, Maharashtra - 400601 Dear Sir, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the Qualified Institutional Placement (“QIP”) of Neogen Chemicals Limited (“the Company”) Pursuant to Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”) and Monitoring Agency Agreement dated September 16, 2026, enclosed herewith the Monitoring Agency Report, issued by Crisil Ratings Limited, Monitoring Agency, as per Schedule XI of the SEBI ICDR Regulations towards utilization of proceeds of QIP for the quarter ended September 30, 2026. Request you to kindly take the same on records. Thanking you, For and on behalf of Crisil Ratings Limited Shounak Chakravarty Director, Ratings (LCG) Report of the Monitoring Agency (MA) Name of the issuer: Neogen Chemicals Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: Crisil Ratings Limited (a) Deviation from the objects: Not applicable (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Shounak Chakravarty Designation of Authorized person/Signing Authority: Director, Ratings (LCG) 1) Issuer Details: Name of the issuer: Neogen Chemicals Limited Names of the promoter: a. Haridas Kanani Family Trust (Beena Haridas Kanani and Harin Haridas Kanani) b. Beena Kanani Family Trust (Haridas Thakarshi Kanani and Harin Haridas Kanani) c. Mr. Harin Haridas Kanani d. Mr. Haridas Thakarshi Kanani Industry/sector to which it belongs: Specialty Chemicals 2) Issue Details Issue Period: September 10, 2026, to September 16, 2026 Type of issue (public/rights): Qualified Institutional Placement (QIP) Type of specified securities: Equity Shares QIP Grading, if any: NA Issue size: Rs 600.00 crore* *Crisil Ratings shall be monitoring the gross proceeds amount. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information/ certifications Comments of the Comments considered by Particulars Reply Monitoring of the Board Monitoring Agency of Directors Agency for preparation of report Proceeds were Statutory Auditors utilized towards Certificate^, repayment of Management loans, working undertaking, capital Placement Whether all utilization is as per the disclosures requirements and No Yes Document dated in the Offer Document? GCP as in line Comments September 16, 2026 with the (hereinafter disclosures referred as “Offer provided in the Document”), Bank Placement Statements Document Source of information/ certifications Comments of the Comments considered by Particulars Reply Monitoring of the Board Monitoring Agency of Directors Agency for preparation of report Whether shareholder approval has been obtained in case of material deviations from NA No Comments Comments expenditures disclosed in the Offer Document? Whether the means of finance for the disclosed No No No Comments objects of the issue has changed? Comments Is there any major deviation observed over the No NA No Comments earlier monitoring agency reports? Comments Statutory Auditors Whether all Government/statutory approvals No NA Certificate^, No Comments related to the object(s) have been obtained? Comments Management undertaking Whether all arrangements pertaining to technical assistance/collaboration are in NA No Comments Comments operation? Are there any favorable events improving the No No No Comments viability of these object(s)? Comments Are there any unfavorable events affecting the No No No Comments viability of the object(s)? Comments Is there any other relevant information that may materially affect the decision making of the No No Comments Comments investors? NA represents Not Applicable ^ Certificate dated October 28, 2026, issued by M/s Chandabhoy & Jassoobhoy, Chartered Accountan [Showing first 8,000 characters — download PDF for full document]